Tuesday, June 13, 2023 4:29:38 PM
Agile Plans to Increase Twirla prescriptions filled through telemedicine platforms that utilize vitaCare, such as Twentyeight Health™
Partnership Expected to Augment Future Growth in the Retail Channel, the Company’s Most-Profitable Channel
Expanding Commercial Reach through Strategic Partnerships Continues to Drive Company’s Belief in Achieving 2023 Net Revenue in the Range of $25-$30 Million
PRINCETON, N.J., June 13, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women's healthcare company, today announced an agreement with vitaCare Prescription Services, a wholly owned subsidiary of GoodRx, to expand patient access and streamline fulfillment for Twirla (levonorgestrel ethinyl estradiol) transdermal system. VitaCare is a technology and services platform that helps patients navigate key access barriers for branded medications.
“The agreement with vitaCare aligns with our strategy to utilize partnerships to efficiently grow Twirla while continuing to responsibly manage our operating expenses,” said Agile Therapeutics’ Chief Commercial Officer Amy Welsh.
“The goal for the vitaCare partnership is to strengthen Twirla’s already meaningful momentum in our most profitable channel – the retail channel. We believe the partnership with vitaCare will create more opportunity to reach new Twirla patients for whom access has been a barrier, while helping existing Twirla patients stay on therapy. Our on-going plan is to expand our commercial reach, which we expect will contribute to reaching our key 2023 financial goals of generating positive cash flow and delivering net revenue in the range of $25-$30 million.”
Agile continues to grow Twirla’s presence on telemedicine platforms, including Twentyeight Health, in addition to existing partners like Pandia Health and Nurx as more women choose telemedicine for their contraceptive needs. Twentyeight Health is a telehealth company providing affordable access and convenience for reproductive and sexual health and recently acquired the platform assets for SimpleHealth. The Company believes that the Twentyeight Health platform will provide an opportunity for more patients to learn about and access Twirla.
Recent AGRX News
- Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/28/2024 12:05:00 PM
- Agile Therapeutics Announces Delisting from Nasdaq • GlobeNewswire Inc. • 03/25/2024 08:30:00 PM
- Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024 • GlobeNewswire Inc. • 03/21/2024 10:35:00 AM
- Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024 • GlobeNewswire Inc. • 03/20/2024 12:15:00 PM
- Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution • GlobeNewswire Inc. • 03/13/2024 11:31:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/23/2024 09:57:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/23/2024 09:55:25 PM
- Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds • GlobeNewswire Inc. • 02/22/2024 02:01:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:30 PM
- Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update • GlobeNewswire Inc. • 02/15/2024 09:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:02:00 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/07/2024 09:51:10 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 03:14:35 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/05/2024 02:21:25 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/02/2024 09:27:13 PM
- The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost • GlobeNewswire Inc. • 01/23/2024 02:29:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/20/2023 01:00:42 PM
- Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage Requirement • GlobeNewswire Inc. • 12/12/2023 01:01:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/11/2023 10:30:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 01:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 01:00:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 01:15:21 PM
- Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/09/2023 01:05:00 PM
- Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023 • GlobeNewswire Inc. • 10/26/2023 12:05:00 PM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM